Biomea Fusion management to participate in upcoming investor conferences
Biomea Fusion said members of management will participate in upcoming investor conferences, according to a company announcement. The company is a clinical-stage diabetes and obesity business.
SAN CARLOS, Calif., Sept.
03, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Company” or “Company management”) NASDAQ:BMEA, a clinical-stage diabetes and obesity company, today announced that members of its management team will participate in the following upcoming investor conferences…